Skip to main content
SpringerLink
Log in

Determination of heparan sulphate in kidney tissues of patients with calcium nephrolithiasis

  • Original Paper
  • Published:
Urological Research Aims and scope Submit manuscript

Abstract

While the pathogenic mechanisms responsible for calcium nephrolithiasis remain unknown, the influence of heparan sulphate proteoglycan (HSPG) on disease progression of other diseases, such as polycystic kidneys and diabetic glomerulosclerosis, makes it an important candidate for the study of stone formation. Using the indirect immunofluorescence assay and image analysis, we were able to quantify and visualize the loss of HSPG localized in the basement membrane of the glomerulus and the mucosa of ureter or renal pelvis in patients with recurrent calcium nephrolithiasis as compared to normal subjects. However, no significant change in HSPG was observed in the basement membrane of the tubular epithelium. The decreased HSPG in the glomerulus may reflect the potentially disrupted anion/neutral barrier for glomerular filtration, which would encourage the accumulation of stone solutes. The drop in HSPG staining intensity in the basement membrane of the mucosa of ureter/renal pelvis may suggest the tendency of adhesion of crystal to urothelial surfaces. Based on these immunological data, it appears that HSPG plays a modulatory role in the pathogenesis of this disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Born J van den, Henvel LPWJ van den, Bakker MAH, Veerkamp JH, Assmann KJM, Berden JHM (1994) Monoclonal antibodies against the protein core and glycosaminoglycan side chain of glomerular heparan sulphate proteoglycan: characterization and immunohistological applications in human tissues. J Histochem Cytochem 42:89

    Google Scholar 

  2. Buck AC (1990) Risk factors in idiopathic stone disease. In: Chisholm GD, Fair WR (eds) Scientific foundations of urology. Year Book Medical, Chicago, p 176

    Google Scholar 

  3. Carone FA, Makino H, Kanwar YS (1988) Basement membrane antigens in renal polycystic disease. Am J Pathol 130:466

    Google Scholar 

  4. Faaber P, Rijke TPM, Van De Puttle LBA, Capel PJA, Berden JHM (1986) Cross-reactivity of human and murine anti-DNA antibodies with heparan sulphate. J Clin Invest 77:1824

    Google Scholar 

  5. Gill WB, Jones KW, Ruggiero KJ (1982) Protective effects of heparin and other sulphated glycosaminoglycans on crystal adhesion to injured urothelium. J Urol 127:152

    Google Scholar 

  6. Hurst RE (1994) Structure, function, and pathology of proteoglycans and glycosaminoglycans in the urinary tract. World J Urol 12:3

    Google Scholar 

  7. Ikeda S, Makino H, Ota Z (1993) Alterations in glomerular extracellular matrix components in glomerulonephritis. Nippon Jinzo Gakkai Shi 35:941

    Google Scholar 

  8. Makino H, Yamasaki Y, Haramoto T, Shikata K, Hironaka K, Ota Z, Kanwar YS (1993) Ultrastructural changes of extracellular matrices in diabetic nephropathy revealed by high resolution scanning and immunoelectron microscopy. Lab Invest 68:45

    Google Scholar 

  9. Olgemoller B, Schleicher E (1993) Alterations in glomerular matrix protein in the pathogenesis of diabetic nephropathy. Clin Invest 71:S13

  10. Pak CYC (1992) Pathophysiology of calcium nephrolithiasis. In: Seldin D, Giebisch G (eds) The kidney: physiology and pathophysiology. Raven, New York, pp 2461

    Google Scholar 

  11. Parsons CL, Stauffer C, Schmidt JD (1980) Bladder-surface glycosaminoglycan: an efficient mechanism of environmental adaptation. Science 208:605

    Google Scholar 

  12. Shum DKY, Gohel MDI (1993) Separate effects of urinary chondroitin sulphate and heparan sulphate on the crystallization of urinary calcium oxalate: differences between stone formers and normal control subjects. Clin Sci 85:33

    Google Scholar 

  13. Shum DKY, Baylis C, Scott JE (1984) A micro puncture and renal clearance study in the rat of the urinary excretion of heparin, chondroitin sulphate and metabolic breakdown products of connective tissue proteoglycans. Clin Sci 67:205

    Google Scholar 

  14. Yamagata M, Saga S, Kato M, Bernfield M, Kimata K (1993) Selective distributions of proteoglycans and their ligands in pericellular matrix of cultured fibroblasts: implications for their roles in cell-substratum adhesion. J Cell Sci 106:55

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Clinical Research, Ministry of Health, Block 6 Level 6, Singapore General Hospital, Outram Road, 0316, Singapore

    V. S. W. Chan

  2. Department of Urology, Singapore General Hospital, Singapore

    E. C. Y. Tan & M. K. Li

Authors
  1. V. S. W. Chan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E. C. Y. Tan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. K. Li
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chan, V.S.W., Tan, E.C.Y. & Li, M.K. Determination of heparan sulphate in kidney tissues of patients with calcium nephrolithiasis. Urol. Res. 23, 339–342 (1995). https://doi.org/10.1007/BF00300024

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00300024

Key words

Search

Navigation